ddt 16 Flashcards

(45 cards)

1
Q

an antibiotic that hasn’t been used in clinics beadier but belonging to class of antibiotics

A

new antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

an antibiotics w mechanism of action never used against bacteria

A

novel antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

infections are mostly associated w

A

invasive medical devices and surgical procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

S.aureus produces

A

4 enzymes ( peniclin binding proteins PBP ) for cell wall biosynthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PBP 1-4 can be modified by

A

b-lactam antibiotics leading to their inhibition and bacterial death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MRSA produced —- which is not inhibited by— and can produce all functions of —-

A
  • altered PBP. (PBP2a)
  • b- lactam
  • all 4 PBP of S aueures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the production of altered PBP is considered to be

A

recent resistance mechanism in gram +ve compared to the b-lactamase is ancient evolutionary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment of infection caused by MRSA

A
  • antibiotics other than penicillin/ b- lactam
    ( almost 50% of mrsa strains r resistant to all but few antibiotics )
  • vancomycin destroys mrsa and resistant bacteria
    ( first case was VRSA and there are 52 VRSA strains )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

novel antibiotics for mrsa treatments

A
  • linezoid ( oxazolidinone )
  • synercid ( combination of streptograms, quinupristin, dalfopristin )
  • daptomycin ( lipopeptide )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

linezolid is a

A

oxazolidinone class of antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

linezoilds works for —- by inhibiting —- in only gram — bacteria

A

mrsa and VRE , inhibition of protein synthesis , gram +ve only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

intravenous treatment caused by VRE, staph. aureus, and strep. pyogen

A

Synercid by inhibiting protein synthesis both agents at same place in the ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

—– when administered individually and —- when in combination

A

bacteriostatic, synerically and becomes bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

intravenous treatment of gram +ve infections by binding to cell membrane and causes depolarisation

A

daptomycin ( cubcin )
- it interrupts protein, dna and rna sythesis
- slow emerges of resistance in clinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

patient being hostiblized for prolonged period of times and receiving multible course of antibiotics results in

A

antibiotic resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

enterococcus faecalis and enterococcus fascium are

A

more difficult to treat and higher incidence of resistance against vancomycin ( 15-20% of isolates )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

32 before emerges requires — genes mutation for resistance against vancomycin but 2-3 years against penicillin requires — mutation

A

5 genes , 1 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

vancomycin works by

A

inhibiting the cell wall beiosystheis and block the substrate while peciline blocks the enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is a glycopeptide antibiotic

20
Q

bacteria becomes resistant when

A
  • loss of a single hydrogen bond = 1,000 folds drop in drug binding affinity ( from D-Ala to D- Lac )
21
Q

Clostridium difficile associated diseases ( CDAD)

A
  • gram +ve
  • requires anaerobic bacterium
  • spores forming
  • toxigenic strains: toxins A + B causes extensive damage to colonic mucosa
22
Q

—- causes major nosocomial diarrhoea

23
Q

more than — produced — and — antibiotic treatment

A

90% after and during

24
Q

treatments of CDAD includes

A

1- medical therapy includes discontinuation of inciting antibiotic if possible
2- specific antibiotic treatment if persisent diarrhoea:
- metrazodiale at first line antibtioc agent
- vancomycin as alternate agent for 2nd line therapy
- both are taken orally

25
20-25% of the patients will get --- of the symptoms once ------
recurrence, vancomycin. metronidazole withdrawal
26
metronidazole is a
nitroaryl compound and exact mechanism is unknwon,
27
how is the prodrug metronidazole is activated
activated by anaerobic organisms by reduction of nitro group to hydroxylamine group. During reduction it can damage bacterial cell components dna protein and mebrance
28
the advantages of metronidazole as a first line therapy
- reserves vancomycin for MRSA - prevent selection if VRE
29
when is vancomycin is used instead of metronidazole
- failure to reposed to metronidazole after 3-5 days - pregnancy , lactation - intolerance to metronidazole - critically ill patients - metronidazole- resistant infecting organisms
30
gram --- is responsible for --- of HAI
gram -ve , 30%
31
gram --- is responsible for --- ICU ( intensive care unit)
gram -ve , 70%
32
the main HAI caused by gram -ve
- pneuminia: associated w mechanical ventilations - bloodstream infections: associated mostly from central vascular catheter and initial infections in the lungs, abdomen, and genitourinary tract - Urianry tract infections (UTI): associated mostly from urtheral cathetrization increased risk from 5-10% best management is to remove the catheter instead of antibiotic treatment
33
many strains of gram -ve bacteria causing HAI are
-multi-drug resistant ( MDR , resist at least 3 different antibiotic classes ) - can have more than 1 resistance mechanism - requires the use of older antibiotic not used before bc toxicity issues lead to polymyxin
34
some organisms resist all currently available antibiotic called
XDR : extreme drug resistance , including polymyxin ( acintobacter baemanni )
35
the antibiotic carbapenems resistance is
carbapanese
36
---- can inactivate all type of b lactam antibiotics and are not inhibited by inhibitors of b- lactamasse aka clavulenic acid which is a clinical challenge
carbapebenases
37
treatment of HAI caused by gram -ve drug resistant
- gram -ve expressing ESBLS ( extended spectrum b- lactamase) : carbapene as meropenum - gram -ve expressibg carbapenemse : colistrin , trigcylin
38
is a carbapenum b lactam antibiotic
meropenum
39
meropenum structure similar to ----
penicillin - bicyclic structure , 1 b lactam ring , 5 membered ring - sulphur is not part of the 5-membered ring , its attached to a ring of functional side chain - carbon- carbon double bond in the 5-membered ring
40
colistin ( polymyxin E)
- peptide antibiotic -polymyxin antibiotic - mixture of 2 cyclic peptide ( colistin A and b) produced by the fermentation of bacillus polymyxa - clinical use is perviously limited bc of nephrotoxity - reserved as last resort antibiotic of MDR gram -ve bacteria - binds to phosphate group in lipid on the cell cytoplasmic membrane and disturbs its integrity
41
reserved as last resort antibiotic of MDR gram -ve bacteria
colistin
42
tigecycline is
novel tetracycline class: glycylclines
43
characterised by additioal glyclyamido substients
tigecyclin and it inhitbis bacteria protein sythesis and is broad spectrum antibiotic
44
all novel antibiotics are effective against gram +ve but not -ve bc
gram -ve outer membrane is the main barrier
45
number of novel classes of antibiotics for gram -ve bacteria under development
NONE LOL